Sustained activation of renal N-methyl-D-aspartate receptors decreases vitamin D synthesis: a possible role for glutamate on the onset of secondary HPT.
N-methyl-D-aspartate (NMDA) receptors (NMDAR) are tetrameric amino acid receptors that act as membrane calcium channels. The presence of the receptor has been detected in the principal organs responsible for calcium homeostasis (kidney, bone, and parathyroid gland), pointing to a possible role in mineral metabolism. The aim of this study was to test the effect of NMDAR activation in the kidney and on 1,25(OH)₂D₃ synthesis. We determined the presence of NMDAR subunits in HK-2 (human kidney cells) cells and proved its functionality. NMDA treatment for 4 days induced a decrease in 1α-hydroxylase levels and 1,25(OH)₂D₃ synthesis through the activation of the MAPK/ERK pathway in HK-2 cells. In vivo administration of NMDA for 4 days also caused a decrease in blood 1,25(OH)₂D₃ levels in healthy animals and an increase in blood PTH levels. This increase in PTH induced a decrease in the urinary excretion of calcium and an increase in urinary excretion of phosphorous and sodium as well as in diuresis. Bone turnover markers also increased. Animals with 5/6 nephrectomy showed low levels of renal 1α-hydroxylase as well as high levels of renal glutamate compared with healthy animals. In conclusion, NMDAR activation in the kidney causes a decrease in 1,25(OH)₂D₃ synthesis, which induces an increase on PTH synthesis and release. In animals with chronic kidney disease, high renal levels of glutamate could be involved in the downregulation of 1α-hydroxylase expression.
Parisi
Eva
E
Institut de Recerca Biomèdica de Lleida, Spain.
Bozic
Milica
M
Ibarz
Mercé
M
Panizo
Sara
S
Valcheva
Petya
P
Coll
Blai
B
Fernández
Elvira
E
Valdivielso
José M
JM
D000818:Animals; D002118:Calcium / Q000097:blood / Q000652:urine; D002460:Cell Line; D003404:Creatinine / Q000097:blood / Q000652:urine; D005260:Female; D018698:Glutamic Acid / Q000378:metabolism*; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000209:etiology*; D007668:Kidney / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D006899:Mixed Function Oxygenases / Q000378:metabolism*; D015675:Osteocalcin / Q000097:blood / Q000652:urine; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000097:blood / Q000652:urine; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000737:chemistry / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D016194:Receptors, N-Methyl-D-Aspartate / Q000235:genetics / Q000378:metabolism*; D014807:Vitamin D / Q000031:analogs & derivatives* / Q000096:biosynthesis / Q000378:metabolism
D010281:Parathyroid Hormone; D010710:Phosphates; D012333:RNA, Messenger; D016194:Receptors, N-Methyl-D-Aspartate; D015675:Osteocalcin; D014807:Vitamin D; D018698:Glutamic Acid; C097949:1,25-dihydroxyvitamin D; D003404:Creatinine; D006899:Mixed Function Oxygenases; D002118:Calcium
Am J Physiol Renal Physiol. 2007 Nov;293(5):F1577-83
17699549
Brain Res. 2000 Feb 28;857(1-2):71-7
10700554
Proc Natl Acad Sci U S A. 1985 Jun;82(12):4270-3
3858880
Nephron Exp Nephrol. 2006;103(3):e126-30
16554663
Endocr Rev. 2005 Feb;26(1):78-113
15689574
Trends Neurosci. 1993 Dec;16(12):521-7
7509523
J Endocrinol. 1969 Nov;45(3):387-400
5358264
Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6988-93
10359826
J Endocrinol. 2007 Oct;195(1):125-31
17911404
Neuroscience. 1999;92(4):1261-72
10426482
FASEB J. 1993 Dec;7(15):1468-74
8262331
J Clin Invest. 1990 Oct;86(4):1313-9
2212016
J Am Soc Nephrol. 2002 May;13(5):1381-4
11961027
Anat Rec. 1951 Sep;111(1):23-47
14885765
Kidney Int. 1981 Oct;20(4):442-51
6273643
J Biol Chem. 1998 Feb 27;273(9):5253-9
9478982
J Clin Invest. 2007 Dec;117(12):4003-8
17992255
Nature. 1993 Jan 7;361(6407):31-9
8421494
Bone. 1998 Apr;22(4):295-9
9556127
Am J Physiol. 1975 Nov;229(5):1170-3
1200136
Am J Physiol. 1966 Mar;210(3):661-6
5933222
Diabetes. 2003 May;52(5):1235-9
12716758
Endocrinology. 1960 Nov;67:570-82
13738473
J Clin Invest. 1996 Jun 1;97(11):2534-40
8647946
Endocrinology. 2008 Apr;149(4):1748-56
18162528
Neuropharmacology. 1995 Oct;34(10):1219-37
8570021
J Bone Miner Res. 1996 Jul;11(7):970-6
8797118
J Am Soc Nephrol. 2004 Aug;15(8):2186-94
15284304
Clin Chem Lab Med. 2006;44(3):237-73
16519596
Kidney Int. 1991 Nov;40(5):961-73
1762300
Bone. 1998 Jun;22(6):645-9
9626403
Kidney Int. 2006 Jan;69(1):33-43
16374421
Am J Physiol Renal Physiol. 2009 Jun;296(6):F1291-6
19357180
Am J Physiol Renal Physiol. 2009 May;296(5):F976-82
19279130
Endocrinology. 1960 Apr;66:610-6
13800268
Science. 1977 Mar 11;195(4282):994-6
841324
J Anat. 1948 Oct;82(Pt 4):233-248.2
17105062
Eur J Pharmacol. 2000 Jun 23;398(3):349-59
10862824
Annu Rev Nutr. 2002;22:139-66
12055341
Am J Physiol Renal Physiol. 2005 Jul;289(1):F8-28
15951480
Eur J Pharmacol. 2008 Jul 28;589(1-3):37-44
18538763
Am J Physiol Renal Physiol. 2002 Sep;283(3):F367-76
12167586
Cell. 1995 Jan 27;80(2):259-68
7834745
J Neurosci. 1994 Mar;14(3 Pt 1):1320-31
8120627
Prog Neurobiol. 2005 Nov;77(4):252-82
16343729
Semin Nephrol. 1989 Mar;9(1):65-71
2662305
J Clin Invest. 1995 Jul;96(1):327-33
7615802
J Clin Invest. 1992 Dec;90(6):2456-63
1469097
Ann N Y Acad Sci. 1955 Apr 27;60(5):776-96
14377312